Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/145339

Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa
Cillóniz, Catia; Gabarrús, Albert; Ferrer Monreal, Miquel; Puig de la Bellacasa, Jordi; Rinaudo, Mariano; Mensa Pueyo, Josep; Niederman, Michael S.; Torres Martí, Antoni
Background: Pseudomonas aeruginosa is not a frequent pathogen in community-acquired pneumonia (CAP). However, in patients with severe CAP, P aeruginosa can be the etiology in 1.8% to 8.3% of patients, with a case-fatality rate of 50% to 100%. We describe the prevalence, clinical characteristics, outcomes, and risk factors associated with CAP resulting from multidrug-resistant (MDR) and non-MDR P aeruginosa. Methods: Prospective observational study of 2,023 consecutive adult patients with CAP with definitive etiology. Results: P aeruginosa was found in 77 (4%) of the 2,023 cases with microbial etiology. In 22 (32%) of the 68 cases of P aeruginosa with antibiogram data, the isolates were MDR. Inappropriate therapy was present in 49 (64%) cases of P aeruginosa CAP, including 17/22 (77%) cases of MDR P aeruginosa CAP. Male sex, chronic respiratory disease, C-reactive protein <12.35 mg/dL, and pneumonia severity index risk class IV to V were independently associated with P aeruginosa CAP. Prior antibiotic treatment was more frequent in MDR P aeruginosa CAP compared with non-MDR P aeruginosa (58% vs 29%, P = .029), and was the only risk factor associated with CAP resulting from MDR P aeruginosa. In the multivariate analysis, age ≥65 years, CAP resulting from P aeruginosa, chronic liver disease, neurologic disease, nursing home, criteria of ARDS, acute renal failure, ICU admission, and inappropriate empiric treatment were the factors associated with 30-day mortality. Conclusions: P aeruginosa is an individual risk factor associated with mortality in CAP. The risk factors described can help clinicians to suspect P aeruginosa and MDR P aeruginosa.
-Pseudomonas
-Pneumònia adquirida a la comunitat
-Resistència als medicaments
-Community-acquired pneumonia
-Drug resistance
cc by-nc-nd (c) Elsevier, 2016
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
Artículo
Artículo - Versión aceptada
Elsevier
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Cillóniz, Catia; Ewig, Santiago; Ferrer Monreal, Miquel; Polverino, Eva; Gabarrús, Albert; Puig de la Bellacasa, Jordi; Mensa Pueyo, Josep; Torres Martí, Antoni
Cillóniz, Catia; Ewig, Santiago; Ferrer Monreal, Miquel; Polverino, Eva; Gabarrús, Albert; Puig de la Bellacasa, Jordi; Mensa Pueyo, Josep; Torres Martí, Antoni
Ceccato, Adrian; Torres Martí, Antoni; Cillóniz, Catia; Amaro, Rosanel; Gabarrús, Albert; Polverino, Eva; Prina, Elena; Garcia Vidal, Carolina; Muñoz Conejero, Eva; Méndez, Cristina; Cifuentes, Isabel; Puig de la Bellacasa, Jordi; Menéndez, Rosario; Niederman, Michael S.
Ceccato, Adrian; Cillóniz, Catia; Martin-Loeches, Ignacio; Ranzani, Otavio T.; Gabarrús, Albert; Bueno, Leticia; Garcia Vidal, Carolina; Ferrer Monreal, Miquel; Niederman, Michael S.; Torres Martí, Antoni
Ceccato, Adrian; Cillóniz, Catia; Martín Loeches, Ignacio; Ranzani, Otavio T.; Gabarrús, Albert; Bueno, Leticia; Garcia Vidal, Carolina; Ferrer Monreal, Miquel; Niederman, Michael S.; Torres Martí, Antoni